1. Articles from PR Newswire

    prnewswire.com

  2. 1-24 of 582 1 2 3 4 ... 23 24 25 »
    1. Neuberger Berman Files Proxy Statement Seeking To Replace Three Verint Directors

      Neuberger Berman Files Proxy Statement Seeking To Replace Three Verint Directors

      NEW YORK, May 13, 2019 /PRNewswire/ -- Neuberger Berman Investment Advisers LLC and certain of its affiliates ("Neuberger Berman") that manage investment funds and client accounts that collectively own approximately 1,743,123 shares, or 2.7%, of the outstanding stock of Verint Systems, Inc. (NASDAQ: VRNT) ("Verint" or the "Company") announced that it has delivered an open letter to Verint stockholders today...

      Read Full Article
    2. Michael J. Wolf Appointed To Sotheby's Board Of Directors

      Michael J. Wolf Appointed To Sotheby's Board Of Directors

      NEW YORK, May 10, 2019 /PRNewswire/ -- Sotheby's (NYSE: BID) announced today that Michael J. Wolf has been unanimously elected to join the Company's Board of Directors. Mr. Wolf is the Chief Executive Officer of Activate, Inc., a management consulting firm he founded in 2009 specializing in technology, internet, media, entertainment, and consumer services businesses...

      Read Full Article
    3. Univar Solutions Appoints Christopher D. Pappas as Independent Lead Director of its Board of Directors

      Univar Solutions Appoints Christopher D. Pappas as Independent Lead Director of its Board of Directors

      DOWNERS GROVE, Ill., May 9, 2019 /PRNewswire/ -- Univar Inc. (NYSE: UNVR) ("Univar Solutions"), a global chemical and ingredient distributor and provider of value-added services, today announced the appointment of Christopher D. Pappas as Independent Lead Director for its Board of Directors.  Pappas succeeds William S. Stavropoulos who will continue to serve on the Board. Pappas will also continue as Nominating and Corporate Governance Committee Chair...

      Read Full Article
    4. Velan Delivers Letter to the Board of Progenics Pharmaceuticals

      Velan Delivers Letter to the Board of Progenics Pharmaceuticals

      ALPHARETTA, Ga., May 6, 2019 /PRNewswire/ -- Velan Capital, L.P. (together with its affiliates, "Velan"), one of the largest stockholders of Progenics Pharmaceuticals, Inc. (the "Company")(NASDAQ: PGNX), today announced that it has delivered a letter to the Board of Directors (the "Board") of the Company expressing its concerns with the Company's persistent underperformance and poor corporate governance practices and stating its intent to hold certain members of the Board accountable at the Company's 2019 Annual Meeting of Stockholders...

      Read Full Article
    5. Karen B. Peetz Elected to Guardian Board of Directors

      Karen B. Peetz Elected to Guardian Board of Directors

      NEW YORK, April 25, 2019 /PRNewswire/ -- The Guardian Life Insurance Company of America® (Guardian), one of the nation's largest mutual life insurers and a leading provider of whole life, individual disability insurance, and employee benefits, announced today that Karen B. Peetz has been elected to its board of directors...

      Read Full Article
    6. Myndshft Names Mark D. Hiatt, MD, to its Board of Directors

      Myndshft Names Mark D. Hiatt, MD, to its Board of Directors

      MESA, Ariz.April 25, 2019 /PRNewswire/ -- Myndshft, a healthcare technology company that automates and simplifies administrative processes, today announced it has named Mark D. Hiatt, MD, MBA, MS, as the newest member of its board of directors. An established physician executive and innovator with experience as a clinician and chief medical officer, Dr. Hiatt currently serves as Vice President of Medical Affairs for Guardant Health, a pioneer in non-invasive cancer diagnostics and the first company to commercialize a comprehensive genomic liquid biopsy...

      Read Full Article
    7. TELA Bio® Appoints Kurt Azarbarzin Chairman of Board of Directors

      TELA Bio® Appoints Kurt Azarbarzin Chairman of Board of Directors

      MALVERN, Pa., April 25, 2019 /PRNewswire/ -- TELA Bio®, Inc., a regenerative medicine company leading the development of advanced medical devices for soft tissue reconstruction, today announced the appointment of Kurt Azarbarzin as Chairman of its Board of Directors. Mr. Azarbarzin is also being appointed to the Compensation Committee...

      Read Full Article
    8. Pegasystems Appoints Christopher Lafond to its Board of Directors

      Pegasystems Appoints Christopher Lafond to its Board of Directors

      CAMBRIDGE, Mass., April 24, 2019 /PRNewswire/ -- Pegasystems Inc. (NASDAQ: PEGA), the software company empowering digital transformation at the world's leading enterprises, today announced it has appointed Christopher Lafond to its board of directors. Mr. Lafond brings to Pega more than two decades of executive leadership experience working with large, publicly-traded, multinational companies...

      Read Full Article
    9. Medallia Names SaaS Veteran Mitchell K. Dauerman to its Board of Directors

      Medallia Names SaaS Veteran Mitchell K. Dauerman to its Board of Directors

      SAN FRANCISCO, April 23, 2019 /PRNewswire/ -- Medallia, Inc. (www.medallia.com), the global experience management leader, today announced the appointment of Mitchell K. Dauerman, former Chief Financial Officer of Ultimate Software who currently serves as the company's EVP of Investor Relations, as a new member of Medallia's board of directors...

      Read Full Article
    10. MDC Partners Announces Board Updates; MDC Reaches Agreement with FrontFour Capital

      MDC Partners Announces Board Updates; MDC Reaches Agreement with FrontFour Capital

      NEW YORK, April 22, 2019 /PRNewswire/ -- (NASDAQ: MDCA) – MDC Partners Inc. ("MDC Partners" or the "Company") today announced several changes to its Board of Directors. First, the Company has reached a settlement agreement (the "Agreement") with FrontFour Capital Group LLC ("FrontFour"). As part of the agreement, MDC will include Kristen O'Hara on its slate of director nominees for election at the 2019 Annual Meeting...

      Read Full Article
    11. UNFI Elects James Muehlbauer to Its Board of Directors

      UNFI Elects James Muehlbauer to Its Board of Directors

      PROVIDENCE, R.I., April 22, 2019 /PRNewswire/ -- United Natural Foods, Inc. (NYSE: UNFI) ("UNFI") today announced it has appointed James Muehlbauer, an experienced financial and strategic executive, to its Board of Directors effective April 22, 2019. This appointment furthers UNFI's commitment to expand the size of its Board and bring on additional expertise in areas that serve UNFI's new strategic objectives following the recent SUPERVALU acquisition. With the addition of Mr. Muehlbauer, UNFI's Board now has nine members...

      Read Full Article
    12. Liberty Mutual Insurance Elects Jay Hooley, State Street Corporation Chairman to the Company's Board of Directors

      Liberty Mutual Insurance Elects Jay Hooley, State Street Corporation Chairman to the Company's Board of Directors

      BOSTONApril 18, 2019 /PRNewswire/ -- David Long, Liberty Mutual Insurance's Chief Executive Officer, today announced that Jay Hooley, Chairman and former Chief Executive Officer of State Street Corporation, has been elected to the insurer's Board of Directors...

      Read Full Article
    13. DowDuPont Announces New Members for Future Board of Directors of DuPont

      DowDuPont Announces New Members for Future Board of Directors of DuPont

      WILMINGTON, Del.April 17, 2019 /PRNewswire/ -- DowDuPont (NYSE: DWDP) today announced three additional members to the future board of directors of DuPont, currently the Specialty Products Division of DowDuPont. The new directors include Frank K. Clyburn, chief commercial officer at Merck & Co., Inc., Terrence R. Curtin, CEO of TE Connectivity, and Frederick M. Lowery, senior vice president and president, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific Inc. With these additions, DuPont expects to have 12 members on its board, effective June 1, 2019...

      Read Full Article
      Mentions: DuPont DowDupont NYSE
    14. Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors

      Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors

      MONTREAL and CHARLOTTE, N.C.April 16, 2019 /PRNewswire/ -- Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular conditions, today announced the appointment of Paul Edick as Chairman of its Board of Directors. Mr. Edick currently serves as Chairman and Chief Executive Officer of Xeris Pharmaceuticals, a publicly traded specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations...

      Read Full Article
    15. Newman's Own Appoints Joe Tripodi to Newman's Own Board of Directors

      Newman's Own Appoints Joe Tripodi to Newman's Own Board of Directors

      WESTPORT, Conn.April 16, 2019 /PRNewswire/ -- Newman's Own, Inc. today announced that Joseph V. Tripodi has been elected to the Newman's Own Board of Directors. Newman's Own, Inc. the food and beverage company founded by actor and philanthropist Paul Newman in 1982, donates 100% of the profits and royalties from Newman's Own products to charity...

      Read Full Article
    1-24 of 582 1 2 3 4 ... 23 24 25 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content